Nephlin T-04

Class: Confidential

Overseer: 1032

Start Date: 06/06/598

Details:

06/06/598
- Beginning genesis of AK-Class subjects via orders of 2440.
12/25/598
- Successful genesis of batch AK-1 has begun, Recombinant DNA appears to be viable.
01/18/599
- AK-1 deemed failure, 87% of embryos lost. Beginning batch 2.
09/28/599
- AK-2 passed successful development, genealogy not as strong as expected, termination of successful subjects probable.
- AK-2 shows little resistance to decentralised variants of 035.
- 682 has requested AK-2-1, request was granted under special circumstances.
- New Recombinant DNA has been synthesised, may offer more resistance to 035.
01/04/672
- (PN-AK-7) Ready for deployment.
- Subjects of AK-5 & AK-6 deployed to Davenport recently appear to have a strange reaction with UP-017. Lattice structure embedded within neural tissue appears to bind differently to most humanoids. While D-Class subjects still appear to be immune, citizens with traces to A & T subjects should be studied.

Notes:

Dr. ████ Davidson - (04/09/602):

Matthew,

I understand that Nephlin is not within the terms of our agreement, however I would appreciate it if I was kept up to date, I'll try and make it worth your while.

From what I understand, you've been trialing a new type of subject? I'd love to learn more.

Dr. ████ Davidson